Search the Newsreel

Is Alto Neuroscience (ANRO) Fully Valued As ALTO 207 Expands With New Funding?

Clearstead Trust LLC Invests $4.98 Million in Palo Alto Networks, Inc. $PANW

Clearstead Trust LLC has made a significant new investment in Palo Alto Networks, Inc. (NASDAQ:PANW), acquiring 14,601 shares valued at approximately $4.98 million. This move positions Palo Alto Networks as the 25th largest holding in Clearstead Trust LLC's portfolio. Other major institutional investors like …

Avalon Trust Co Buys Shares of 111,705 Palo Alto Networks, Inc. $PANW

Avalon Trust Co acquired a new stake of 111,705 shares in Palo Alto Networks (NASDAQ:PANW) during the second quarter, valued at approximately $38.09 million. This acquisition makes Palo Alto Networks the 10th largest holding for Avalon Trust Co, comprising 2.3% of its investment portfolio. …

6,219 Shares in Palo Alto Networks, Inc. $PANW Acquired by Bridgewater Advisors Inc.

Bridgewater Advisors Inc. has acquired a new stake of 6,219 shares in Palo Alto Networks, Inc. (NASDAQ:PANW), valued at approximately $2.16 million, according to its latest SEC filing. Other institutional investors like Norges Bank, Bank of America Corp DE, and Vanguard Group Inc. have …

Understanding Momentum Shifts in (VLTO)

This article analyzes Veralto Corp (NASDAQ: VLTO) using AI models to identify momentum shifts and provide trading strategies. Key findings indicate mixed sentiment across different time horizons and no clear resistance levels above the current price, suggesting potential upside. Three distinct institutional trading strategies—Position …

Why Alto Neuroscience (ANRO) Is Up 13.5% After Expanding ALTO-207 Phase 3 And Securing New Funding

Alto Neuroscience (ANRO) saw a 13.5% stock increase after expanding its ALTO-207 Phase 3 trial for treatment-resistant depression and securing approximately $100 million in new funding. Despite ongoing net losses, the company aims to validate its data-driven approach, with short-term focus on the expanded …

Palo Alto Networks (PANW) Deepens Index Presence and Integrations: How Durable Is Its Platform Advantage?

Palo Alto Networks was recently added to Israel’s TA-35 and TA-125 indices, and FireMon integrated its security platform with Palo Alto Networks’ Strata Cloud Manager. These developments reinforce the company's strategy of platformized, AI-driven cybersecurity. The article emphasizes that while index additions are notable, …

PANW vs CRWD vs AVGO: Morningstar Has A 'Top Pick' Trading At A 40% Discount After Earnings

Why Veralto (VLTO) Is Back In The Spotlight

Veralto (VLTO) is gaining investor attention due to improved earnings estimates, a positive outlook driven by U.S. infrastructure and semiconductor demand, and its recent acquisition of In-Situ Inc. While the stock's share price has seen recent positive momentum, its P/E ratio is currently above …

BIP Wealth LLC Makes New Investment in Palo Alto Networks, Inc. $PANW

Alto Neuroscience (NYSE:ANRO) Upgraded to "Sell" at Wall Street Zen

Wall Street Zen upgraded Alto Neuroscience (NYSE:ANRO) from "strong sell" to "sell," despite the broader analyst consensus remaining a "Moderate Buy" with a target price of $36.62. Shares opened at $32.14, near their 12-month high, and the company reported a quarterly loss of $0.65 …

Ist Palo Alto Networks (PANW) Nach KI Sicherheitsalarm Bereits Voll Eingepreist?

Palo Alto Networks (NASDAQ:PANW) Stock Price Down 3% - Time to Sell?

Alto Neuroscience (ANRO) investor group discloses 9.99% ownership cap

An investor group comprising Perceptive Advisors LLC, Joseph Edelman, and Perceptive Life Sciences Master Fund, Ltd. has reported a beneficial ownership of 9.99% in Alto Neuroscience (ANRO). This ownership, totaling 4,176,711 shares, includes common stock and pre-funded warrants, with the exercise of warrants capped …

Palo Alto Networks Inc Stock (PANW) Closed Down by 3.33% on Aug 14: A Full Analysis

Vestal Point Capital (ANRO) discloses 785,000-share Alto Neuroscience position in 13G/A

Vestal Point Capital, LP and Ryan Wilder have filed an amended Schedule 13G, disclosing a 2.2% beneficial ownership in Alto Neuroscience, Inc., totaling 785,000 shares. These shares are held through a fund and a managed account advised by Vestal Point Capital, with both shared …

What Could Palo Alto Networks (PANW) Gain From Its New Policy Control Integration?

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Palo Alto Networks (NasdaqGS:PANW) and FireMon announced completion of FireMon's integration with Palo Alto Networks Strata Cloud Manager, delivering new policy governance and risk validation capabilities for …

T. Rowe Price Investment Management (VLTO) discloses 5.6% Veralto Corp stake

T. Rowe Price Investment Management has disclosed a 5.6% stake in Veralto Corp (VLTO), amounting to 13,722,619 shares of common stock as of June 30, 2026. This ownership, reported via a Schedule 13G filing, indicates sole voting power over 13,257,448 shares and sole dispositive …

Alto Neuroscience, Inc. Stock 12‑Month Price Target Raised to $37.56, Implies 16% Upside

Alto Neuroscience, Inc. (ANRO) has seen its average 12-month price target increased to $37.56 by 9 analysts, suggesting a 16% potential upside from its August 13 closing price. The consensus rating for the stock remains a "Buy" from 11 analysts.

Jim Cramer Admitted ‘Trimming’ Palo Alto & CrowdStrike Holdings For His Charitable Trust

Jim Cramer has consistently recommended buying cybersecurity stocks for more than a year. Two firms that regularly cross his radar are Palo Alto Networks, Inc. (NASDAQ:PANW) and CrowdStrike Holdings, Inc. (NASDAQ:CRWD). While the pair operates in the same industry, in today's AI-driven software era, …

Analysts Offer Insights on Healthcare Companies: Alto Neuroscience, Inc. (ANRO) and Owlet (OWLT)

Two healthcare companies, Alto Neuroscience, Inc. (ANRO) and Owlet (OWLT), recently received bullish ratings from analysts. Myles Minter from William Blair reiterated a Buy rating for Alto Neuroscience, with a consensus price target of $35.71. Jonna Kim from TD Cowen also reiterated a Buy …

Palo Alto Networks Unveils Commercial Velocity Program To Target Midmarket, SMB Through The Channel: Exclusive

Palo Alto Networks is launching a "Commercial Velocity Program" to expand its reach into the midmarket and SMB segments exclusively through channel partners. The initiative, which includes new financial incentives for partners, aims to drive the adoption of Palo Alto Networks' cybersecurity platforms and …

Palo Alto Networks (PANW) Outperforms Broader Market: What You Need to Know

Palo Alto Networks (PANW) ended the recent trading session at $396.00, demonstrating a +2.32% change from the preceding day's closing price. The stock's performance was ahead of the S&P 500's daily gain of 0.65%. Elsewhere, the Dow saw an upswing of 0.13%, while the …

Palo Alto Networks (NASDAQ:PANW) Stock Price Up 2.3% on Analyst Upgrade

Stocks making big moves yesterday: Everpure, Palo Alto Networks, Ridgepost Capital, Nabors Industries, and Hewlett Packard Enterprise

Stocks making big moves yesterday: Everpure, Palo Alto Networks, Ridgepost Capital, Nabors Industries, and Hewlett Packard Enterprise Check out the companies making headlines yesterday: Everpure (NYSE:P): Data storage solutions provider Everpure (NYSE:P) rose by 9.7% on Monday after Susquehanna upgraded the stock to Positive …

Alto Neuroscience stock hits all-time high at 32.74 USD

Alto Neuroscience Inc. (ANRO) stock has reached an all-time high of $32.74, marking a 906.09% increase over the past year. Despite this surge, InvestingPro suggests the stock may be overvalued. The company recently announced a stock offering to raise $100 million, received a reiterated …

Gilbert Nathan Purchases 50,000 Shares of Alto Ingredients (NASDAQ:ALTO) Stock

Director Gilbert Nathan recently purchased 50,000 shares of Alto Ingredients (NASDAQ:ALTO) stock for $4.15 per share, totaling $207,500, increasing his stake by 6.2% to 856,393 shares. The purchase follows Alto Ingredients exceeding quarterly earnings expectations, reporting $0.15 EPS against an $0.08 consensus and $245.7 …

Wedbush Adjusts Price Target on Alto Neuroscience to $26 From $24, Keeps Neutral Rating

Wedbush has increased its price target for Alto Neuroscience from $24 to $26, while maintaining a Neutral rating on the stock. The article also briefly mentions Unity Software's fourth-quarter financial results, including a 35% year-over-year revenue increase to $609 million and a quarterly loss …

Can't get access to GPT-5.6-Cyber? Palo Alto Networks will take your money

Palo Alto Networks has launched an expanded Daybreak program, becoming one of the first major cybersecurity vendors to offer a security service utilizing OpenAI's GPT-5.6-Cyber model. This move highlights a growing trend where frontier AI model companies create a segmented market for advanced security …

Why Is Palo Alto Networks Stock Surging on Thursday?

Alto Neuroscience (NYSE:ANRO) Trading 8% Higher Following Earnings Beat

Alto Neuroscience (NYSE:ANRO) shares rose 8% after reporting a quarterly loss of $0.65 per share, surpassing the consensus estimate of a $0.73 loss. Analysts maintain a "Moderate Buy" consensus rating with an average price target of $36.62, and institutional investors like Commodore Capital and …

Insider Move: Gilbert E Nathan Invests $207K In Alto Ingredients Stock

Palo Alto Networks Inc Stock (PANW) Moved Up by 3.06% on Aug 13: Facts Behind the Movement